Novel inhibitors of the histone methyltransferase DOT1L show potent antileukemic activity in patient-derived xenografts

被引:36
作者
Perner, Florian [1 ,2 ,3 ]
Gadrey, Jayant Y. [1 ,2 ,3 ]
Xiong, Yijun [1 ,2 ,3 ]
Hatton, Charles [1 ,2 ,3 ]
Eschle, Benjamin K. [1 ,2 ,3 ]
Weiss, Andreas [4 ]
Stauffer, Frederic [4 ]
Gaul, Christoph [4 ]
Tiedt, Ralph [4 ]
Perry, Jennifer A. [1 ,2 ,3 ]
Armstrong, Scott A. [1 ,2 ,3 ]
Krivtsov, Andrei V. [1 ,2 ,3 ]
机构
[1] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Novartis Inst Biomed Res, Basel, Switzerland
关键词
GENE-EXPRESSION; MLL; LEUKEMIA;
D O I
10.1182/blood.2020006113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1983 / 1988
页数:7
相关论文
共 17 条
[1]  
Bernt KM, 2011, EPIGENOMICS-UK, V3, P667, DOI [10.2217/EPI.11.98, 10.2217/epi.11.98]
[2]   MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L [J].
Bernt, Kathrin M. ;
Zhu, Nan ;
Sinha, Amit U. ;
Vempati, Sridhar ;
Faber, Joerg ;
Krivtsov, Andrei V. ;
Feng, Zhaohui ;
Punt, Natalie ;
Daigle, Amanda ;
Bullinger, Lars ;
Pollock, Roy M. ;
Richon, Victoria M. ;
Kung, Andrew L. ;
Armstrong, Scott A. .
CANCER CELL, 2011, 20 (01) :66-78
[3]   A novel small molecule menin-MLL inhibitor for potential treatment of MLL-rearranged leukemias and NPM1/DNMT3A-mutant AML [J].
Burrows, Francis ;
Wu, Tao ;
Kessler, Linda ;
Li, Shuangwei ;
Zhang, Jingchuan ;
Zarrinkar, Patrick ;
Li, Liansheng ;
Cierpicki, Tomasz ;
Grembecka, Jolanta ;
Ren, Pingda ;
Liu, Yi .
MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
[4]   Mixed- Phenotype Acute Leukemia Diagnostic Criteria and Pitfalls [J].
Charles, Nathan J. ;
Boyer, Daniel F. .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (11) :1462-1468
[5]   Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond [J].
Chen, Chun-Wei ;
Armstrong, Scott A. .
EXPERIMENTAL HEMATOLOGY, 2015, 43 (08) :673-684
[6]   DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia [J].
Chen, Chun-Wei ;
Koche, Richard P. ;
Sinha, Amit U. ;
Deshpande, Aniruddha J. ;
Zhu, Nan ;
Eng, Rowena ;
Doench, John G. ;
Xu, Haiming ;
Chu, Scott H. ;
Qi, Jun ;
Wang, Xi ;
Delaney, Christopher ;
Bernt, Kathrin M. ;
Root, David E. ;
Hahn, William C. ;
Bradner, James E. ;
Armstrong, Scott A. .
NATURE MEDICINE, 2015, 21 (04) :335-+
[7]   Potent inhibition of DOT1L as treatment of MLL-fusion leukemia [J].
Daigle, Scott R. ;
Olhava, Edward J. ;
Therkelsen, Carly A. ;
Basavapathruni, Aravind ;
Jin, Lei ;
Boriack-Sjodin, P. Ann ;
Allain, Christina J. ;
Klaus, Christine R. ;
Raimondi, Alejandra ;
Scott, Margaret Porter ;
Waters, Nigel J. ;
Chesworth, Richard ;
Moyer, Mikel P. ;
Copeland, Robert A. ;
Richon, Victoria M. ;
Pollock, Roy M. .
BLOOD, 2013, 122 (06) :1017-1025
[8]   Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l [J].
Deshpande, Aniruddha J. ;
Chen, Liying ;
Fazio, Maurizio ;
Sinha, Amit U. ;
Bernt, Kathrin M. ;
Banka, Deepti ;
Dias, Stuart ;
Chang, Jenny ;
Olhava, Edward J. ;
Daigle, Scott R. ;
Richon, Victoria M. ;
Pollock, Roy M. ;
Armstrong, Scott A. .
BLOOD, 2013, 121 (13) :2533-2541
[9]   Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].
Doehner, Hartmut ;
Estey, Elihu ;
Grimwade, David ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Larson, Richard A. ;
Levine, Ross L. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel ;
Sierra, Jorge ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wei, Andrew H. ;
Lowenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2017, 129 (04) :424-447
[10]   MLL translocations, histone modifications and leukaemia stem-cell development [J].
Krivtsov, Andrei V. ;
Armstrong, Scott A. .
NATURE REVIEWS CANCER, 2007, 7 (11) :823-833